Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.090
+0.090 (4.50%)
At close: Jun 26, 2026, 4:00 PM EDT
2.040
-0.050 (-2.39%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Daré Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 378.47% from the current stock price of 2.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2026.
Analyst Ratings
The average analyst rating for Daré Bioscience stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +282.78% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +474.16% | May 15, 2026 |
Financial Forecast
Revenue This Year
2.11M
from 1.03M
Increased by 104.96%
Revenue Next Year
7.39M
from 2.11M
Increased by 249.97%
EPS This Year
-0.95
from -1.20
EPS Next Year
-0.51
from -0.95
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.7M | 9.4M | |
| Avg | 2.1M | 7.4M | |
| Low | 152,460 | 5.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 453.3% | 346.0% | |
| Avg | 105.0% | 250.0% | |
| Low | -85.2% | 153.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.95 | -0.51 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.